- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07832565
Sandwich vs. Mixed Bone Augmentation for Implant Placement
Comparison of Dental Implant Placement With Simultaneous Sandwich Bone Augmentation vs. Mixed Bone Augmentation: a Randomized Controlled Pilot Study
This study is being done to see which of two common grafting techniques-mixing two different grafting materials or layering two grafting materials-works better to augment bone volume next to participant's dental implant(s). The investigators want to know which technique results in better bone augmentation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Guo-Hao Lin, DDS, MS
- Phone Number: 415-476-1731
- Email: guo-hao.lin@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- Periodontology Clinic, UCSF School of Dentistry
-
Contact:
- Guo-Hao Lin, DDS, MS
- Phone Number: 415-476-1731
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Minimum dentition of 20 permanent teeth
- Single edentulous site at maxillary premolar, canine, lateral incisor, or central incisor
- Adjacent teeth present with sufficient clearance for an implant crown
- Ridge width between 4 mm and 7 mm at the edentulous site
Exclusion Criteria:
-
Systemic criteria:
- Current heavy smokers (>10 cigarettes per day) or heavy smokers who quitted less than 1 year
- Pregnancy or lactating mothers
- Diseases of the immune system or any medical condition that may influence the treatment outcome (for examples uncontrolled diabetes (HbA1c >7), uncontrolled cardiovascular disease, neurologic or psychiatric disorders, systemic infections, history of radiation therapy in the head and neck area, current use of oral bisphosphonates for >3 years or history of IV bisphosphonates use, current alcoholism or drug abuse, etc.)
-
Intraoral criteria:
- Acute infection at/or adjacent to the edentulous site (e.g., sinus tract, swelling, etc.)
- Observable gingival changes due to use of medications such as calcium antagonists, anticonvulsives, immunosuppressants, anti-inflammatory medications, etc.)
- Generalized uncontrolled dental diseases, e.g. caries, periodontal diseases, etc.
- Uncontrolled periodontal disease
- Poor oral hygiene (>20% plaque score)
-
CBCT criteria:
• More than 7 mm of alveolar ridge with at the edentulous site present on CBCT scans
-
Intraoperative criteria:
- An implant without primary stability >35N
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sandwich bone augmentation
|
The exposed threads on the buccal side of the implant will be grafted with three distinct layers of grafting materials. |
|
Active Comparator: Mixed bone augmentation
|
The exposed threads on the buccal side of the implant will be grafted with three grafting materials mixed together. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dental Implant's Horizontal Bone Gain (mm) Measured by Cone-Beam Computed Tomography (CBCT)
Time Frame: 1 year after crown delivery
|
Horizontal bone gain will be measured in millimeters (mm) by comparing CBCT images obtained at baseline and follow-up. Measurements will be performed using computer-based imaging software to quantify changes in horizontal alveolar ridge width at the treated site. |
1 year after crown delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implant Survival Rate Assessed by Clinical Examination
Time Frame: 1 year after crown delivery
|
Implant survival will be assessed by the treating provider through clinical examination at the specified follow-up time point. An implant will be considered surviving if it remains present and in function at the time of evaluation. |
1 year after crown delivery
|
|
Pink Esthetic Score (PES) of Dental Implant Site Assessed by a Blinded Examiner
Time Frame: 1 year after crown delivery
|
Peri-implant esthetic outcomes will be evaluated by a blinded examiner using the Pink Esthetic Score (PES). The PES will be determined according to the predefined components of the scoring system, with higher scores indicating a more favorable peri-implant soft-tissue esthetic outcome. |
1 year after crown delivery
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Guo-Hao Lin, DDS, MS, University of California, San Francisco
Publications and helpful links
General Publications
- Buser D, Wittneben J, Bornstein MM, Grutter L, Chappuis V, Belser UC. Stability of contour augmentation and esthetic outcomes of implant-supported single crowns in the esthetic zone: 3-year results of a prospective study with early implant placement postextraction. J Periodontol. 2011 Mar;82(3):342-9. doi: 10.1902/jop.2010.100408. Epub 2010 Sep 10.
- Wang HL, Misch C, Neiva RF. "Sandwich" bone augmentation technique: rationale and report of pilot cases. Int J Periodontics Restorative Dent. 2004 Jun;24(3):232-45.
- Buser D, Bragger U, Lang NP, Nyman S. Regeneration and enlargement of jaw bone using guided tissue regeneration. Clin Oral Implants Res. 1990 Dec;1(1):22-32. doi: 10.1034/j.1600-0501.1990.010104.x.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 26-46484
- CA-0285698 (Other Grant/Funding Number: Geistlich)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.